Literature DB >> 21817096

Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation.

Kieran L Quinn1, Melanie Henriques, Arata Tabuchi, Bing Han, Hong Yang, Wei-Erh Cheng, Soumitra Tole, Hanpo Yu, Alice Luo, Emmanuel Charbonney, Elizabeth Tullis, Alan Lazarus, Lisa A Robinson, Heyu Ni, Blake R Peterson, Wolfgang M Kuebler, Arthur S Slutsky, Haibo Zhang.   

Abstract

OBJECTIVE: Neutrophils are involved in the inflammatory responses during atherosclerosis. Human neutrophil peptides (HNPs) released from activated neutrophils exert immune modulating properties. We hypothesized that HNPs play an important role in neutrophil-mediated inflammatory cardiovascular responses in atherosclerosis. METHODS AND
RESULTS: We examined the role of HNPs in endothelial-leukocyte interaction, platelet activation, and foam cell formation in vitro and in vivo. We demonstrated that stimulation of human coronary artery endothelial cells with clinically relevant concentrations of HNPs resulted in monocyte adhesion and transmigration; induction of oxidative stress in human macrophages, which accelerates foam cell formation; and activation and aggregation of human platelets. The administration of superoxide dismutase or anti-CD36 antibody reduced foam cell formation and cholesterol efflux. Mice deficient in double genes of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein (LRP), and mice deficient in a single gene of LRP8, the only LRP phenotype expressed in platelets, showed reduced leukocyte rolling and decreased platelet aggregation and thrombus formation in response to HNP stimulation.
CONCLUSIONS: HNPs exert proatherosclerotic properties that appear to be mediated through LRP8 signaling pathways, suggesting an important role for HNPs in the development of inflammatory cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817096      PMCID: PMC4909471          DOI: 10.1161/ATVBAHA.111.227116

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  54 in total

1.  Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3.

Authors:  Marta Rodríguez-García; Harold Oliva; Núria Climent; Felipe García; José M Gatell; Teresa Gallart
Journal:  J Leukoc Biol       Date:  2007-08-07       Impact factor: 4.962

2.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

Review 3.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

4.  Immunohistochemical localization of defensin in human coronary vessels.

Authors:  E S Barnathan; P N Raghunath; J E Tomaszewski; T Ganz; D B Cines
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections.

Authors:  T Ihi; M Nakazato; H Mukae; S Matsukura
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.

Authors:  Raquel Melchior Roman; Paulo Vicente Camargo; Flávia Kessler Borges; Ana Paula Rossini; Carisi Anne Polanczyk
Journal:  Coron Artery Dis       Date:  2010-05       Impact factor: 1.439

7.  The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis.

Authors:  A A Higazi; T Nassar; T Ganz; D J Rader; R Udassin; K Bdeir; E Hiss; B S Sachais; K J Williams; E Leitersdorf; D B Cines
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

8.  Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress.

Authors:  Farisa Syeda; Elizabeth Tullis; Arthur S Slutsky; Haibo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

9.  Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.

Authors:  Adili Reheman; Hong Yang; Guangheng Zhu; Wuxun Jin; Feng He; Christopher M Spring; Xufang Bai; Peter L Gross; John Freedman; Heyu Ni
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

10.  Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries.

Authors:  Panagiotis Kougias; Hong Chai; Peter H Lin; Qizhi Yao; Alan B Lumsden; Changyi Chen
Journal:  J Vasc Surg       Date:  2006-02       Impact factor: 4.268

View more
  17 in total

Review 1.  Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis.

Authors:  G E Sanda; A D Belur; H L Teague; Nehal N Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-10-30       Impact factor: 5.113

Review 2.  The complexity of arterial classical monocyte recruitment.

Authors:  Maik Drechsler; Oliver Soehnlein
Journal:  J Innate Immun       Date:  2013-04-05       Impact factor: 7.349

3.  α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol.

Authors:  Rami Abu-Fanne; Emad Maraga; Ihab Abd-Elrahman; Aviel Hankin; Galia Blum; Suhair Abdeen; Nuha Hijazi; Douglas B Cines; Abd Al-Roof Higazi
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

4.  Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.

Authors:  Rami Abu-Fanne; Victoria Stepanova; Rustem I Litvinov; Suhair Abdeen; Khalil Bdeir; Mohamed Higazi; Emad Maraga; Chandrasekaran Nagaswami; Alexander R Mukhitov; John W Weisel; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

5.  Multi-allelic haplotype association identifies novel information different from single-SNP analysis: a new protective haplotype in the LRP8 gene is against familial and early-onset CAD and MI.

Authors:  Gong-Qing Shen; Domenico Girelli; Lin Li; Oliviero Olivieri; Nicola Martinelli; Qiuyun Chen; Eric J Topol; Qing K Wang
Journal:  Gene       Date:  2013-03-21       Impact factor: 3.688

6.  A Subregion of Reelin Suppresses Lipoprotein-Induced Cholesterol Accumulation in Macrophages.

Authors:  Emmanuel U Okoro; Hongfeng Zhang; Zhongmao Guo; Fang Yang; Carlie Smith; Hong Yang
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies.

Authors:  Naif A M Almontashiri; Ragnar O Vilmundarson; Nima Ghasemzadeh; Sonny Dandona; Robert Roberts; Arshed A Quyyumi; Hsiao-Huei Chen; Alexandre F R Stewart
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

8.  LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice.

Authors:  Maria Borrell-Pagès; July Carolina Romero; Lina Badimon
Journal:  J Cell Mol Med       Date:  2015-02-05       Impact factor: 5.310

9.  Monocyte interaction accelerates HCl-induced lung epithelial remodeling.

Authors:  Qiuhua Chen; Alice Aili Luo; Haibo Qiu; Bing Han; Bruce Hsin-Kuo Ko; Arthur S Slutsky; Haibo Zhang
Journal:  BMC Pulm Med       Date:  2014-08-09       Impact factor: 3.317

10.  Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products.

Authors:  Silke Niemann; Anne Bertling; Martin F Brodde; Anke C Fender; Hélène Van de Vyver; Muzaffar Hussain; Dirk Holzinger; Dirk Reinhardt; Georg Peters; Christine Heilmann; Bettina Löffler; Beate E Kehrel
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.